NYLI U.S. Large Cap RandD Leaders ETF (LRND)

On our desk, evaluating the NYLI U.S. Large Cap RandD Leaders ETF (formerly the IQ U.S. Large Cap RandD Leaders ETF) comes down to its unique screening methodology. By combining RandD intensity directly with ROIC, the fund filters for companies that successfully convert research expenditure into tangible future earnings. Even though the market capitalization sits around $11.88M with relatively thin daily trading volumes, the underlying strategy appeals to long-term allocators seeking targeted innovation exposure without picking individual tech or health-care winners.

Watching the order book and recent regulatory disclosures for LRND, I noticed that short interest jumped by 185.23% in the latest reporting period. While the absolute number of shares sold short is minuscule at just 753 shares—yielding a days-to-cover ratio of 0.0—the dramatic percentage swing highlights microscopic tactical positioning by short-term traders. Combined with a 52-week trading range spanning from $35.87 to $47.63, investors must weigh these liquidity nuances against the fund's broader growth-oriented asset management framework.

When analyzing the Process and Parent pillars for LRND from a quantitative research perspective, Morningstar's Medalist rating provides a helpful baseline for assessing the repeatable nature of the NYLI U.S. Large Cap RandD Leaders Index. Analysts reviewing this ETF must examine how effectively the proprietary metrics filter out inefficient spenders. The core exposure targets sustainable RandD investment, making it a distinct instrument for portfolio construction when assessing structural growth in large-cap equities.